| ²é¿´: 842 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õß×¼²©Ê¿½«ÔùËÍÄú 2 ¸ö½ð±Ò | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
×¼²©Ê¿½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
ËõдËù´ú±íµÄÎïÖÊ
|
||
| T3PÊÇʲôÎïÖÊ£¿ÊÇÉú»¯·´Ó¦ÖеÄÒ»¸öÎïÖÊ¡£ |
» ²ÂÄãϲ»¶
346Çóµ÷¼Á[0856]
ÒѾÓÐ7È˻ظ´
һ־Ըɽ´ó07»¯Ñ§ 332·Ö ËÄÁù¼¶Òѹý ±¾¿ÆÉ½¶«Ë«·Ç Çóµ÷¼Á£¡
ÒѾÓÐ3È˻ظ´
310Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
»úеר˶299Çóµ÷¼ÁÖÁ²ÄÁÏ
ÒѾÓÐ4È˻ظ´
070300»¯Ñ§319Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
08¹¤¿Æ 320×Ü·Ö Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸Ìì½ò´óѧ»¯Ñ§¹¤ÒÕרҵ£¨081702£©315·ÖÇóµ÷¼Á
ÒѾÓÐ12È˻ظ´
307Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
weiac
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ½ð±Ò: 2784.3
- Ìû×Ó: 1227
- ÔÚÏß: 62.6Сʱ
- ³æºÅ: 422595
- ×¢²á: 2007-07-15
- רҵ: ÉúÎﻯ¹¤ÓëʳƷ»¯¹¤
¡ï
×¼²©Ê¿(½ð±Ò+1,VIP+0):ʵ¼ÊÉÏÊÇÈý̼ÌÇÁ×ËᣬÊÇ3-Á×Ëá¸ÊÓͺͶþôDZûͪÁ×ËáµÄ»ìºÏÎï
×¼²©Ê¿(½ð±Ò+1,VIP+0):ʵ¼ÊÉÏÊÇÈý̼ÌÇÁ×ËᣬÊÇ3-Á×Ëá¸ÊÓͺͶþôDZûͪÁ×ËáµÄ»ìºÏÎï
| Èç¹û˵ÊÇÉúÎﻯѧ·½ÃæµÄÄÚÈÝ£¬t3pºÜ¿ÉÄÜÊÇÖ¸Triiodothyropropionic acid ¼´ (P-[4-(3'-iodo-4'-hydroxyphenoxy)-3,5-diiodophenyllpropionic acid) |
3Â¥2008-06-09 01:56:05
shaojh
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 4443.5
- ºì»¨: 2
- Ìû×Ó: 1828
- ÔÚÏß: 198.9Сʱ
- ³æºÅ: 569293
- ×¢²á: 2008-06-05
- ÐÔ±ð: GG
- רҵ: ʳƷ¼Ó¹¤¼¼Êõ
¡ï ¡ï
×¼²©Ê¿(½ð±Ò+2,VIP+0):ллÄãµÄÈÈÇé,´ð°¸²»ÊǺܶÔ,ÎÒÊÇѧÉúÎﻯѧµÄ,ºÇºÇ.ËõдËù´ú±íµÄÎïÖÊÌ«¶àÁË.
×¼²©Ê¿(½ð±Ò+2,VIP+0):ллÄãµÄÈÈÇé,´ð°¸²»ÊǺܶÔ,ÎÒÊÇѧÉúÎﻯѧµÄ,ºÇºÇ.ËõдËù´ú±íµÄÎïÖÊÌ«¶àÁË.
|
2-Propanephosphonic acid anhydride 2-±ûÍéËáôû ²Î¼ûÎÄÏ×£º2-Propanephosphonic acid anhydride(T3P)-mediated segment coupling and head-to-tail cyclization of sterically hindered peptides |

2Â¥2008-06-06 10:34:58













»Ø¸´´ËÂ¥